These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17120478)

  • 21. Hyperlactatemia and in utero exposure to antiretrovirals: is the control group the clue?
    Soler-Palacín P; Martín-Nalda A; Martínez-Gómez X; Melendo S; Riudor E; Arranz JA; Espiau M; Figueras C
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):752-8. PubMed ID: 22010980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [German-Austrian guidelines for HIV therapy during pregnancy (May, 2001, update].
    Buchholz B; ;
    Dtsch Med Wochenschr; 2003 May; 128 Suppl 1():S19-31. PubMed ID: 12736864
    [No Abstract]   [Full Text] [Related]  

  • 23. Hemangiomas and other congenital malformations in infants exposed to antiretroviral therapy in utero.
    De Santis M; Cavaliere AF; Caruso A; Villa P; Tamburrini E; Cauda R; Fundaro C; Genovese O
    JAMA; 2004 Jan; 291(3):305. PubMed ID: 14734592
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiretroviral therapy and congenital abnormalities in infants born to HIV-infected women in the UK and Ireland, 1990-2007.
    Townsend CL; Willey BA; Cortina-Borja M; Peckham CS; Tookey PA
    AIDS; 2009 Feb; 23(4):519-24. PubMed ID: 19165088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiretroviral therapy during pregnancy and premature birth: analysis of Swiss data.
    Rudin C; Spaenhauer A; Keiser O; Rickenbach M; Kind C; Aebi-Popp K; Brinkhof MW; ;
    HIV Med; 2011 Apr; 12(4):228-35. PubMed ID: 20726902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Teratogenicity risk of antiretroviral therapy in pregnancy.
    Watts DH
    Curr HIV/AIDS Rep; 2007 Aug; 4(3):135-40. PubMed ID: 17883999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case 1: Preterm Neonate with Hydrops and Lactic Acidosis.
    Szafron V; Kazerouninia A; Gokulakrishnan G
    Neoreviews; 2019 Sep; 20(9):e520-e523. PubMed ID: 31477600
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunological and hematological effects of perinatal exposure to antiretroviral drugs in HIV exposed, non infected children.
    Shah I
    Indian Pediatr; 2013 Jun; 50(6):565-6. PubMed ID: 23942399
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of antiretroviral therapy on occurrence of pre-eclampsia.
    Mawson AR
    Lancet; 2003 Jan; 361(9354):347-8. PubMed ID: 12559889
    [No Abstract]   [Full Text] [Related]  

  • 30. Protease inhibitor treatment in HIV pregnant women. Is it safe for newborns?
    García-Tejedor A; Perales A; Maiques V
    Int J Gynaecol Obstet; 2002 Feb; 76(2):175-6. PubMed ID: 11818114
    [No Abstract]   [Full Text] [Related]  

  • 31. Antiretroviral pharmacology: special issues regarding pregnant women and neonates.
    Mirochnick M; Best BM; Clarke DF
    Clin Perinatol; 2010 Dec; 37(4):907-27, xi. PubMed ID: 21078458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Premature labour precipitated by highly active antiretroviral therapy: an adverse reaction in a newly diagnosed HIV-positive patient.
    Broom J; Sowden D
    Sex Health; 2011 Sep; 8(3):436-8. PubMed ID: 21851788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiretroviral therapy in pregnant women of Florence.
    Trotta M; Meli M; Ginelli R; Sbaragli S; Leoncini F
    Int J Infect Dis; 2001; 5(4):230-1. PubMed ID: 11953225
    [No Abstract]   [Full Text] [Related]  

  • 34. Antiretroviral therapy and mother-to-child transmission of HIV-1.
    Newell ML; Thorne C
    Expert Rev Anti Infect Ther; 2004 Oct; 2(5):717-32. PubMed ID: 15482235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Option B+ for prevention of mother-to-child transmission of HIV in resource-constrained settings: great promise but some early caution.
    Shaffer N; Abrams EJ; Becquet R
    AIDS; 2014 Feb; 28(4):599-601. PubMed ID: 24469000
    [No Abstract]   [Full Text] [Related]  

  • 36. [In-utero antiretroviral exposure and mitochondrial toxicity in a cohort of uninfected infants born to HIV-1-infected women].
    Fernández Ibieta M; Cano JM; Amador JT; González-Tomé MI; Martín SG; Gómez MN; de José MI; Beceiro J; Iglesias E; Prieto L; Santos MJ; Guardia NM; Roa MA; Regidor J
    An Pediatr (Barc); 2010 Oct; 73(4):180-8. PubMed ID: 20951949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cohort profile: the Swiss HIV Cohort study.
    ; Schoeni-Affolter F; Ledergerber B; Rickenbach M; Rudin C; Günthard HF; Telenti A; Furrer H; Yerly S; Francioli P
    Int J Epidemiol; 2010 Oct; 39(5):1179-89. PubMed ID: 19948780
    [No Abstract]   [Full Text] [Related]  

  • 38. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
    Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
    Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The safety of highly active antiretroviral therapy for the HIV-positive pregnant mother and her baby: is 'the more the merrier'?
    Martin F; Taylor GP
    J Antimicrob Chemother; 2009 Nov; 64(5):895-900. PubMed ID: 19706669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tolerance of antiretroviral drugs during pregnancy].
    Blanche S; Warszawski J
    Med Sci (Paris); 2013 Apr; 29(4):383-8. PubMed ID: 23621933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.